Overview
Germany-based input device maker's fiscal 2025 revenue fell 15%, missing analyst expectations
Adjusted EBITDA for fiscal 2025 missed analyst expectations
Q4 Peripherals segment revenue and gross margin improved
Outlook
Cherry SE focuses on enhancing liquidity to reinforce financial foundation
Company sees high-margin opportunities in healthcare despite regulatory delays
Cherry SE aims to advance transformation in Peripherals segment
Result Drivers
COMPONENTS WEAKNESS - Revenue in the Components segment remained under pressure, turning negative for the year due to strategic restructuring costs
PERIPHERALS IMPROVEMENT - Peripherals segment saw revenue and margin growth in Q4, attributed to strategic realignment efforts
EHEALTH TERMINALS GROWTH - eHealth terminals business revenue grew by 26% year-over-year, despite regulatory delays impacting expected revenues
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
Miss
EUR 94.30 mln
EUR 101.70 mln (3 Analysts)
FY Adjusted EBITDA
Miss
-EUR 9.80 mln
-EUR 6.90 mln (3 Analysts)
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the computer hardware peer group is "buy."
Wall Street's median 12-month price target for Cherry SE is €0.65, about 14.8% above its January 27 closing price of €0.57
Press Release: ID:nEQ8C47t9a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)